Replies to post #337881 on Amarin Corp Plc (AMRN)

[ORBAPU]

Thanks. Much appreciated.

[mrmainstreet]

Excellent work getting a response Cap. If you're up to collecting questions we should do this each quarter and let them know retail is watching closely and not going anywhere.

[Pharmacydude]

Capt
Some people talk (complain), others act.
Thanks!

[sts66]

Wow - I've never seen AMRN been this open about answering retailer's questions before - great idea to create an investor group and create a single point of contact (you) for them to deal with - they knew you would disseminate their replies on this board and it would spread around via Twitter and ST's.

I do have a big nit to pick with this part of the answer to question 2:

they [scrips] are growing faster than most brands in our field

Absolute BS - they are totally stagnant, zero growth in 2021, let alone "faster" than anyone else.

[Jasbg]

CaptB@ You have achieved what nobody before you have' - serious answers for every answer you asked IR.
---------------

For whom looked closely - the modernization/updating of IT - Homepage - Presentations etc. has been improving for the last couple of years.

So things 'are moving at Amarin' - even though Nevada ruling truly Chocked this Company.
---------------

Why nobody from Amarin signs the 'answers you get' is a bit weird.

Somebody must be responsible for Investor Contact, and the answers are generally the most serious ever' - so why hide the identity of this person. It does devaluate the response to some degree - have to say.

Jasbg

[Birdbrain Ideas]

Getting these questions answered was a great accomplishment. Congrats. As an investor who is considerably underwater, these answers provide me some oxygen and give me reason to hold steady for now.

These answers also make me think that someone at Amarin monitors this board and tries to ensure decent info reaches us and the craziest misinformation gets shot down.

I especially liked the responses regarding the effect COVID-19 has had on the ability to reach U.S. doctors and the hint that there's a lot more going on than we may think behind the scenes based on the reluctance the company would ever have to talking about interest in a buyout or partnership. My guess is that partnership in Europe is likely if Amarin can't score a fast enough rollout and if sales in the U.S. do indeed pick up, making fast, big sales in Europe less critical.

[Number sleven]

Captain, Are you going to put together another set of investor questions for the next earnings. If so I would like to know what the status of amr-102 is.
Thanks,
Sleven,